Medicare MRI Restrictions Removed For Cardiac Device Patients
Executive Summary
The US Centers for Medicare and Medicaid Services followed through with a plan to expand its national coverage policy for MRI scans, removing contraindications and clinical-study requirements for patients with pacemakers, implantable cardioverter defibrillators and other cardiac rhythm devices.
You may also be interested in...
MRI And Cardiac-Rhythm Devices: A Match Made In Medicare
A proposed coverage policy from the US Centers for Medicare and Medicaid Services would not only cover magnetic resonance imaging for patients with an implanted cardiac rhythm management device with an FDA-approved indication for MRI-compatibility, but will also cover MRI in patients with devices without that FDA labeling in certain circumstances.
Market Advantage Of 'MR-Conditional' Device Labeling Fades
Abbott Laboratories and Boston Scientific recently logged approvals that bring the firms closer to parity with Medtronic in being able to market their cardiac rhythm management devices as compatible with MRI scans. But CMS, the US Medicare agency, is currently considering a coverage policy that make so-called "MR-conditional" product labeling less significant.
MRI Coverage Policies Reconsidered By US Medicare Agency
CMS has opened a national coverage analysis for MRI, but the agency does not provide many details as to what prompted the coverage review or what changes it might consider making to covered or noncovered MRI indications.